The purpose of this article is to discuss the current role of radiation therapy in vulvar cancer and especially to review the recent literature relative to the use of intensity-modulated radiotherapy (IMRT) in disease management. Owing to the low incidence of vulvar cancer, at present there are no available results of cooperative prospective trials. As evidenced in dosimetric and preliminary retrospective clinical studies, the use of IMRT has resulted in superior normal tissue sparing and lower rates of acute and chronic toxicities compared to previous studies that used conventional approaches. Data on long-term outcomes in these patients remain limited.
SiegelRMaJZouZJemalACancer statistics, 2014. CA Cancer J Clin.2014;64 (1):9–29.
2.
JudsonPLHabermannEBBaxterNNDurhamSBVirnigBATrends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol.2006;107 (5):1018–1022.
3.
HamplMDeckers-FigielSHamplJAReinDBenderHGNew aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol.2008;109 (3):340–345.
4.
InsingaRPLiawKLJohnsonLGMadeleineMMA systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev.2008;17 (7):1611–1622.
5.
WerenneXHermesseJCouckePLouviauxIGoffinF[Clinical case of the month. The role of radiotherapy for the treatment of advanced squamous cell carcinoma of the vulva. Case report and review of the literature]. Rev Med Liege.2013;687-8:391–395[Article in French].
6.
HackerNFBerekJSLagasseLDLeuchterRSMooreJGManagement of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol.1983;61 (4):408–412.
7.
HeapsJMFuYSMontzFJHackerNFBerekJSSurgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol.1990;38 (3):309–314.
8.
WoelberLEulenburgCChoschzickMPrognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer.2012;22 (3):503–508.
9.
WoelberLMahnerSVoelkerKClinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res.2009;29 (2):545–552.
10.
PecorelliSRevised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet.2009;105 (2):103–104.
11.
WaySCarcinoma of the vulva. Am J Obstet Gynecol.1960;79:692–697.
12.
TaussigFJCancer of the vulva: an analysis of 155 cases (1911-1940). Am J Obstet Gynecol.1940;40 (5):764–769.
13.
MichelettiLBarberisFTecniche chirurgiche attuali nel carcinoma vulvare. Riv It Ost Gin.2007;15:727–732.
14.
MichelettiLPretiMSurgery of the vulva in vulvar cancer. Best Pract Res Clin Obstet Gynaecol.2014;28 (7):1074–1087.
15.
BurkeTWStringerCAGershensonDMEdwardsCLMorrisMWhartonJTRadical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol.1990;38 (3):328–332.
16.
HackerNFLeuchterRSBerekJSCastaldoTWLagasseLDRadical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol.1981;58 (5):574–579.
17.
ThamKFShepherdJHLoweDGHudsonCNVan DamPAEarly vulval cancer: the place of conservative management. Eur J Surg Oncol.1993;19 (4):361–367.
18.
Van der ZeeAGJOonkMHDe HulluJASentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol.2008;26 (6):884–889.
19.
LevenbackCFAliSColemanRLLymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. J Clin Oncol.2012;30 (31):3786–3791.
20.
CovensAVellaETKennedyEBReadeCJJimenezWLeTSentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations. Gynecol Oncol.2015;137 (2):351–361.
21.
Te GrootenhuisNCvan der ZeeAGJvan DoornHCSentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol.2016;140 (1):8–14.
22.
RadziszewskiJKowalewskaMJedrzejczakTThe accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol.2010;116 (3):473–477.
23.
RobisonKRoqueDMcCourtCLong-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone. Gynecol Oncol.2014;133 (3):416–420.
FaughtWJeffreyJBrysonPet al;SOGC/GOC/SCC Policy and Practice Guidelines Committee. Management of squamous cell cancer of the vulva. J Obstet Gynaecol Can.2006;28 (7):640–645.
FaulCMMirmowDHuangQGersztenKDayRJonesMWAdjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys.1997;38 (2):381–389.
29.
ViswanathanANPintoAPSchultzDBerkowitzRCrumCPRelationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol.2013;130 (3):545–549.
30.
HomesleyHDBundyBNSedlisAAdcockLRadiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol.1986;68 (6):733–740.
31.
KunosCSimpkinsFGibbonsHTianCHomesleyHRadiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol.2009;114 (3):537–546.
32.
MahnerSJueckstockJHilpertFet al;AGO-CaRE 1 investigators. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst.2015;107 (3):1–12.
33.
HanSCKimDHHigginsSACarcangiuMLKacinskiBMChemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys.2000;47 (5):1235–1244.
34.
MulayimNFoster SilverDSchwartzPEHigginsSChemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol.2004;93 (3):659–666.
35.
van DoornHCAnsinkAVerhaar-LangereisMStalpersLNeoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev.2006;3:CD003752.
36.
MooreDHThomasGMMontanaGSSaxerAGallupDGOltGPreoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys.1998;42 (1):79–85.
37.
MontanaGSThomasGMMooreDHPreoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys.2000;48 (4):1007–1013.
38.
BeriwalSCoonDHeronDEPreoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol Oncol.2008;109 (2):291–295.
39.
LandoniFManeoAZanettaGConcurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol.1996;61 (3):321–327.
40.
EifelPJMorrisMBurkeTWLevenbackCGershensonDMProlonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol.1995;59 (1):51–56.
41.
BeriwalSShuklaGShindeAPreoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys.2013;85 (5):1269–1274.
42.
WhitakerSJKirkbridePArnottSJHudsonCNShepherdJHA pilot study of chemo-radiotherapy in advanced carcinoma of the vulva. Br J Obstet Gynaecol.1990;97:436–442.
43.
LupiGRaspagliesiFZucaliRCombined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer.1996;77:1472–1478.
44.
GaudineauAWeitbruchDQuetinPNeoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva. Oncol Lett.2012;4 (4):719–722.
45.
ReadeCJEirikssonLRMackayHSystemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol.2014;132:780–789.
46.
ShylasreeTSBryantAHowellsREJChemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev.2011;4:CD003752.
47.
WahlenSASlaterJDWagnerRJConcurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer.1995;75 (9):2289–2294.
48.
HanSCKimDHHigginsSACarcangiuMLKacinskiBMChemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys.2000;47 (5):1235–1244.
49.
MooreDHAliSKohWJA phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. Gynecol Oncol.2012;124 (3):529–533.
50.
VargoJABeriwalSVulvar Cancer. In: Target volume deliniation for conformal and intensity-modulatid radiation therapy. Lee NY, Riaz N, Lu JJ, edsSpringer.2015;349–358.
51.
HeronDEGersztenKSelvarajRNConventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol.2003;91 (1):39–45.
52.
MundtAJLujanAERotmenschJIntensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys.2002;52 (5):1330–1337.
53.
GarofaloMLujanAMundtAIntensity-modulated radiation therapy in the treatment of vulvar carcinoma. A feasibility study. Paper presented at the 88th Annual Meeting of the Radiologic Society of North America. Chicago, IL, December 5, 2002.
54.
BeriwalSHeronDEKimHIntensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys.2006;64 (5):1395–1400.
55.
MakRHHalaszLMTanakaCKOutcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol.2011;120 (1):101–107.
56.
BloemersMCPortelanceLRuoRParkerWSouhamiLA dosimetric evaluation of dose escalation for the radical treatment of locally advanced vulvar cancer by intensity-modulated radiation therapy. Med Dosim.2012;37 (3):310–313.
